Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes
Clinical trial NCT04962906 · COMPLETED
Trial details
- NCT number
- NCT04962906
- Sponsor
- Ministerio de Salud de Ciudad Autónoma de Buenos Aires
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2021-08-05
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.